# Apton Biosystems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/apton-biosystems

- Industry: Biotechnology
- Headquarters: Pleasanton, US
- Website: www.aptonbio.com
- Total disclosed funding: $24M
- Latest round: Series A (Jun 30, 2021)
- Investors on record: 3

## About

Founded in 2012 and based in California, US, Apton Biosystems, Inc. operates as a biotechnology company that develops a sequencing platform for genetic analysis. The firm was founded by Bryan Staker and Linda Liu. In August 2023, Pacific Biosciences of California, Inc. acquired Apton Biosystems, Inc. from Khosla Ventures, Casdin Capital, and Kern Capital Management LLC for USD 110 million. 

Apton Biosystems, Inc. provides Super-Res sequencing and single-molecule detection systems for large-scale clinical applications such as early cancer detection and population sequencing.

## Funding rounds

- Series A, Jun 30, 2021, $24M — Khosla Ventures, Casdin Capital, Kern Capital Management LLC

## Investors

- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series A
- Kern Capital Management LLC — Series A